ClinVar Miner

Submissions for variant NM_000546.6(TP53):c.1149C>T (p.Leu383=)

gnomAD frequency: 0.00004  dbSNP: rs373710656
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000162452 SCV000212805 likely benign Hereditary cancer-predisposing syndrome 2014-08-06 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV000206094 SCV000261005 likely benign Li-Fraumeni syndrome 2024-01-25 criteria provided, single submitter clinical testing
Counsyl RCV000410097 SCV000487941 likely benign Li-Fraumeni syndrome 1 2015-12-04 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000162452 SCV000537510 likely benign Hereditary cancer-predisposing syndrome 2015-12-14 criteria provided, single submitter clinical testing
Mendelics RCV000989696 SCV001140235 likely benign Squamous cell carcinoma of the head and neck 2019-05-28 criteria provided, single submitter clinical testing
GeneDx RCV001711320 SCV001940215 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV001711320 SCV002047298 likely benign not provided 2021-01-04 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000162452 SCV002582198 likely benign Hereditary cancer-predisposing syndrome 2022-06-18 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000410097 SCV002582761 likely benign Li-Fraumeni syndrome 1 2022-06-18 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV000410097 SCV004017851 benign Li-Fraumeni syndrome 1 2023-04-11 criteria provided, single submitter clinical testing This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing.
CeGaT Center for Human Genetics Tuebingen RCV001711320 SCV004184643 likely benign not provided 2024-03-01 criteria provided, single submitter clinical testing TP53: BP4, BP7
All of Us Research Program, National Institutes of Health RCV000206094 SCV004823713 likely benign Li-Fraumeni syndrome 2023-12-18 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001354955 SCV001549689 uncertain significance Carcinoma of colon no assertion criteria provided clinical testing The TP53 p.Leu383= variant was not identified in the literature nor was it identified in the LOVD 3.0 or UMD-LSDB databases. The variant was also identified in dbSNP (ID: rs373710656) as "With Likely benign allele" and ClinVar (classified as likely benign by Invitae, Counsyl, Ambry Genetics and Color). The variant was identified in control databases in 9 of 246266 chromosomes at a frequency of 0.00004 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European in 8 of 111716 chromosomes (freq: 0.00007) and Latino in 1 of 33582 chromosomes (freq: 0.00003), while it was not observed in the African, Ashkenazi Jewish, East Asian, Finnish, Other, or South Asian populations. The p.Leu383= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. However, 1 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.